3.40
price up icon1.19%   0.04
after-market After Hours: 3.42 0.02 +0.59%
loading
Cytomx Therapeutics Inc stock is traded at $3.40, with a volume of 1.71M. It is up +1.19% in the last 24 hours and up +70.00% over the past month. CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
See More
Previous Close:
$3.36
Open:
$3.4359
24h Volume:
1.71M
Relative Volume:
0.52
Market Cap:
$560.70M
Revenue:
$101.21M
Net Income/Loss:
$-569.00K
P/E Ratio:
-170.00
EPS:
-0.02
Net Cash Flow:
$-56.88M
1W Performance:
+3.66%
1M Performance:
+70.00%
6M Performance:
+538.50%
1Y Performance:
+195.65%
1-Day Range:
Value
$3.30
$3.44
1-Week Range:
Value
$3.06
$3.49
52-Week Range:
Value
$0.40
$3.49

Cytomx Therapeutics Inc Stock (CTMX) Company Profile

Name
Name
Cytomx Therapeutics Inc
Name
Phone
650.515.3185
Name
Address
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
Employee
121
Name
Twitter
@cytomxinc
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
CTMX's Discussions on Twitter

Compare CTMX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CTMX
Cytomx Therapeutics Inc
3.40 554.11M 101.21M -569.00K -56.88M -0.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-22-25 Initiated Cantor Fitzgerald Overweight
Sep-17-25 Resumed Barclays Overweight
Jul-31-25 Initiated Oppenheimer Outperform
May-15-25 Upgrade H.C. Wainwright Neutral → Buy
Apr-14-25 Resumed Piper Sandler Overweight
May-28-24 Upgrade Piper Sandler Neutral → Overweight
May-09-24 Upgrade Wedbush Neutral → Outperform
May-06-24 Upgrade Jefferies Hold → Buy
Apr-22-24 Upgrade JP Morgan Underweight → Neutral
Nov-14-22 Downgrade BMO Capital Markets Outperform → Market Perform
Jul-07-22 Downgrade Jefferies Buy → Hold
Jul-07-22 Downgrade Mizuho Buy → Neutral
Jul-07-22 Downgrade Piper Sandler Overweight → Neutral
Jul-07-22 Downgrade Wedbush Outperform → Neutral
Jun-24-22 Initiated BMO Capital Markets Outperform
Jan-18-22 Upgrade Barclays Underweight → Overweight
Nov-15-21 Initiated BTIG Research Buy
May-28-21 Downgrade Barclays Equal Weight → Underweight
Mar-29-21 Initiated JP Morgan Overweight
Mar-23-21 Upgrade Jefferies Hold → Buy
Sep-22-20 Downgrade Guggenheim Buy → Neutral
Jun-01-20 Downgrade Jefferies Buy → Hold
May-14-20 Reiterated H.C. Wainwright Buy
Mar-24-20 Upgrade Wedbush Neutral → Outperform
Mar-04-20 Initiated Barclays Equal Weight
Nov-20-19 Initiated Guggenheim Buy
Nov-11-19 Downgrade Wedbush Outperform → Neutral
Jun-13-19 Initiated Mizuho Buy
May-14-19 Initiated Cantor Fitzgerald Overweight
Mar-11-19 Initiated Barclays Overweight
Nov-26-18 Initiated Piper Jaffray Overweight
Oct-15-18 Initiated Goldman Neutral
Sep-13-18 Initiated H.C. Wainwright Buy
Jun-01-18 Initiated SunTrust Buy
Jan-05-18 Initiated Citigroup Buy
Sep-08-17 Initiated Wedbush Outperform
Mar-27-17 Initiated H.C. Wainwright Buy
Mar-02-17 Initiated Instinet Buy
Jan-03-17 Downgrade Oppenheimer Outperform → Perform
Nov-02-15 Initiated Oppenheimer Outperform
View All

Cytomx Therapeutics Inc Stock (CTMX) Latest News

pulisher
12:11 PM

Has CytomX Therapeutics Inc. formed a bullish divergenceJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com

12:11 PM
pulisher
11:52 AM

Intraday pattern recognizer results for CytomX Therapeutics Inc.2025 Year in Review & Reliable Volume Spike Trade Alerts - newser.com

11:52 AM
pulisher
10:04 AM

Evaluating CytomX Therapeutics Inc. with trendline analysisQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - newser.com

10:04 AM
pulisher
09:59 AM

CytomX Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com

09:59 AM
pulisher
09:39 AM

Key metrics from CytomX Therapeutics Inc.’s quarterly data2025 Momentum Check & Weekly Sector Rotation Insights - newser.com

09:39 AM
pulisher
05:48 AM

Is CytomX Therapeutics Inc. meeting your algorithmic filter criteriaEarnings Risk Summary & High Accuracy Buy Signal Tips - newser.com

05:48 AM
pulisher
03:00 AM

How CytomX Therapeutics Inc. stock compares to market leaders2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

03:00 AM
pulisher
Oct 12, 2025

Can CytomX Therapeutics Inc. rally from current levelsNew Guidance & AI Powered Market Trend Analysis - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Oct 12, 2025
pulisher
Oct 11, 2025

CytomX Therapeutics (NASDAQ:CTMX) Shares Down 7%Should You Sell? - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

CytomX Therapeutics (NASDAQ:CTMX) Hits New 52-Week High After Analyst Upgrade - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Developing predictive dashboards with CytomX Therapeutics Inc. dataJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

CytomX Therapeutics (NASDAQ:CTMX) Raised to "Hold (C-)" at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Custom watchlist performance reports with CytomX Therapeutics Inc.2025 Breakouts & Breakdowns & Real-Time Volume Triggers - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why CytomX Therapeutics Inc. (6C1) stock is a strong analyst pickJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Exit strategy if you’re trapped in CytomX Therapeutics Inc.Entry Point & Low Risk Entry Point Tips - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

CytomX: A Fresh Start With New Drugs After Total Pipeline Failure (NASDAQ:CTMX) - Seeking Alpha

Oct 06, 2025
pulisher
Oct 06, 2025

Will CytomX Therapeutics Inc. stock maintain dividend yieldPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting price anomalies in CytomX Therapeutics Inc. with AIEarnings Performance Report & Risk Managed Trade Strategies - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is CytomX Therapeutics Inc. (6C1) stock attractive for growth fundsWeekly Market Outlook & Weekly Stock Performance Updates - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Multi factor analysis applied to CytomX Therapeutics Inc.July 2025 Breakouts & Precise Trade Entry Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Risk adjusted return profile for CytomX Therapeutics Inc. analyzedMarket Trend Report & Intraday High Probability Setup Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Using AI based signals to follow CytomX Therapeutics Inc.2025 Buyback Activity & Precise Buy Zone Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will CytomX Therapeutics Inc. (6C1) stock beat international competitionTrade Volume Report & Free Technical Confirmation Trade Alerts - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

CytomX Therapeutics Hits New 52-Week High of $3.48, Up 105.52% - Markets Mojo

Oct 04, 2025
pulisher
Oct 04, 2025

CytomX Therapeutics Hits New 52-Week High at $3.28 - Markets Mojo

Oct 04, 2025
pulisher
Oct 03, 2025

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Down 3.8%Should You Sell? - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Is CytomX Therapeutics Inc. stock ready for a breakoutQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will CytomX Therapeutics Inc. stock continue dividend increasesBuy Signal & Risk Controlled Stock Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is CytomX Therapeutics Inc. stock reversal real or fakeQuarterly Portfolio Report & Expert Approved Momentum Trade Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What drives CytomX Therapeutics Inc stock priceStock Price Forecasts & Free Superior Trading Gains - earlytimes.in

Oct 03, 2025
pulisher
Oct 03, 2025

What earnings margins imply for CytomX Therapeutics Inc. (6C1) stockJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

What technical signals suggest for CytomX Therapeutics Inc. stock - newser.com

Oct 03, 2025

Cytomx Therapeutics Inc Stock (CTMX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Cytomx Therapeutics Inc Stock (CTMX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Ogden Christopher
Chief Financial Officer
Jun 16 '25
Sale
2.69
10,614
28,540
226,271
Ogden Christopher
Chief Financial Officer
Jun 13 '25
Sale
2.95
1,641
4,841
199,385
BELVIN MARCIA
SVP, Chief Scientific Officer
Jun 13 '25
Option Exercise
0.00
37,500
0
286,136
BELVIN MARCIA
SVP, Chief Scientific Officer
Jun 16 '25
Sale
2.69
13,884
37,334
272,252
McCarthy Sean A.
CEO
Jun 13 '25
Option Exercise
0.00
150,000
0
1,145,195
McCarthy Sean A.
CEO
Jun 16 '25
Sale
2.69
55,511
149,264
1,089,684
McCarthy Sean A.
CEO
Mar 18 '25
Sale
0.60
37,656
22,556
995,195
Ogden Christopher
Chief Financial Officer
Mar 18 '25
Sale
0.60
8,551
5,122
201,026
Chu Yu-Waye
Chief Medical Officer
Mar 18 '25
Sale
0.60
4,025
2,411
135,725
ROWLAND LLOYD A
General Counsel
Mar 18 '25
Sale
0.60
10,203
6,112
120,594
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):